FT218

Little biotech makes deep cuts as it struggles to get narcolepsy drug approved amid months of regulatory limbo
Endpoints
Fri, 07/1/22 - 09:38 am
Avadel
FDA
nacrolepsy
layoffs
FT218
Avadel's Once-Nightly Narcolepsy Drug Hits Three Co-Primary Endpoints in Late-Stage Trial
BioSpace
Mon, 04/27/20 - 07:26 pm
Avadel
clinical trials
narcolepsy
FT218
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy